AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

Webinar: Do You Have an Effective Oversight Plan of Your CRO-Vendor? How Are You Measuring It? ICH E6 R2 Requirements for Vendor Oversight

Wednesday, January 29, 2020  |  11:00am – 12:00pm EST

Sponsor Responsibilities for Quality Management (Section 5.0 of ICH E6 (R2)) requires that Sponsors oversee trial-related duties and functions, including those that are subcontracted by CROs (5.2.2). Quality assurance has changed from assurance of conformity to the assurance that process performance and quality are managed over the (relationship and) trial life cycle. Focusing monitoring and oversight resources on risks that matter has become an obligation.

 

Key Takeaways:

  1. Risk-based monitoring is just one component of risk management activities.
  2. Value is derived from using risk management in the prevention of issues related to human subject protection and reliability of clinical trial results.
  3. Risk Management programs require a structure to support repeatability but need to be flexible enough to adapt to the various situations that may arise.

 

This webinar is ideally suited for:

  • Quality Management/Clinical Quality Management
  • Clinical Quality Assurance/QA/CQA
  • Clinical Quality Control/QC/CQC
  • Clinical Operations/Management/Research/Development
  • Compliance/Clinical Compliance/Regulatory Compliance
  • Monitoring/Site Management/Study Management
  • Clinical Outsourcing/Vendor Management/Third Party Management
  • Good Clinical Practice/GCP
  • Auditing/Auditor
  • Clinical Risk/Risk Assessment
  • Regulatory Affairs
  • Medical Affairs

 

Presented by: Brigid Flanagan, Senior Consultant, The Avoca Group

Brigid Flanagan is a research professional with 20+ years in clinical operations. In her role as Senior Consultant for The Avoca Group, Brigid provides input on operational plans, vendor qualification, and oversight for pharmaceutical clients conducting trials in the US and EU. She is passionate about research and the benefits it offers to participants. Brigid has been an active member of ACRP since 1998 and most recently was Vice Chair of their Professional Ethics Committee. She has an undergraduate degree in Sociology, trained as an RN in the UK, and completed a Masters in Bioethics at Union Graduate College/Mount Sinai School of Medicine in New York, NY.

 

Join Avoca’s session on February 24 at ExL’s 4th European Clinical Quality Risk Management Forum.